Skip to main content

François Roy, Suzanne Vinet, Brian White-Guay

Génome Québec appointed François Roy, Suzanne Vinet, and Brian White-Guay to its board of directors. Roy has extensive experience as a corporate director and executive in the public and private sectors. He was with the Société générale de financement du Québec and then served as CFO for Québecor. 

Vinet was deputy minister at Agriculture and Agri-Food Canada. Previously, she was president at Canada Economic Development for Québec Regions and associate deputy minister at Health Canada. 

White-Guay has been a member of AmorChem's investment committee since 2011 and joined the faculty of pharmacy at Université de Montréal as a professor in 2008. Prior to that, he was a vice president at Merck, responsible for all clinical operations and medical departments worldwide. He previously was vice president of regulatory affairs for Europe for Merck.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.